Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Ryuji Nakano"'
Autor:
Naoki Yamashita, Tetsuya So, Takeaki Miyata, Takashi Yoshimatsu, Ryuji Nakano, Tsunehiro Oyama, Wataru Matsunaga, Akinobu Gotoh
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Cancer stem cells (CSCs) are major contributors to the malignant transformation of cells because of their capacity for self-renewal. Aldehyde dehydrogenase1A1 (ALDH1A1) and CD133 are promising candidate of CSC markers in non-small cell lung
Externí odkaz:
https://doaj.org/article/cc1d8c5c5d324c569595cb458ca351cb
Autor:
Saori ITO, Atsuji MATSUYAMA, Hiroshi YAMADA, Chie INABA, Masami KUDO, Atsuko MATSUSHITA, Satoko SHIOTANI, Yasuyuki NISHIYAMA, Ryuji NAKANO
Publikováno v:
The Journal of the Japanese Society of Clinical Cytology. 62:111-115
Autor:
Tsunehiro Oyama, Ryuji Nakano, Takeaki Miyata, Takashi Yoshimatsu, Tetsuya So, Akinobu Gotoh, Naoki Yamashita, Wataru Matsunaga
Background Cancer stem cells (CSCs) are major contributors to the malignant transformation of cells because of their capacity for self-renewal. Although several CSC markers have been identified in various tumor types, they are primarily used as cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a92795e305c08f9f52d5a8545142e680
https://doi.org/10.21203/rs.3.rs-948192/v1
https://doi.org/10.21203/rs.3.rs-948192/v1
Autor:
Naoki Yamashita, Tetsuya So, Takeaki Miyata, Takashi Yoshimatsu, Ryuji Nakano, Tsunehiro Oyama, Wataru Matsunaga, Akinobu Gotoh
Publikováno v:
Scientific Reports
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Cancer stem cells (CSCs) are major contributors to the malignant transformation of cells because of their capacity for self-renewal. Aldehyde dehydrogenase1A1 (ALDH1A1) and CD133 are promising candidate of CSC markers in non-small cell lung cancer (N
Publikováno v:
Journal of Atherosclerosis and Thrombosis
Autor:
Tetsuya So, Takeaki Miyata, Naoki Yamashita, Takashi Yoshimatsu, Wataru Matsunaga, Akinobu Gotoh, Ryuji Nakano, Tsunehiro Oyama
Publikováno v:
Anticancer research. 41(2)
Background/aim CD133 is a promising candidate marker for cancer stem cells. However, clinical studies on CD133 expression in human lung adenocarcinoma have not yet been conducted. We hypothesized that CD133 expression in lung adenocarcinoma is a poor
Autor:
Ryuji Nakano, Takashi Yoshimatsu, Tetsuya So, Tsunehiro Oyama, Naoki Yamashita, Akinobu Gotoh, Takeaki Miyata, Wataru Matsunaga
Publikováno v:
Personalized Medicine Universe. 9:64-65
Autor:
Ke-Yong Wang, Tetsuya So, Sohsuke Yamada, Akihide Tanimoto, Naoki Yamashita, Ryuji Nakano, Shohei Shimajiri
Publikováno v:
Cardiovascular Pathology. 28:68-70
We demonstrated an extremely unusual case of an 83-year-old male's sudden death secondary to characteristic myocardial necrosis and fibrosis with calcification and multinucleated giant cells infiltration, possibly due to sepsis and Stage IV pulmonary
Autor:
Mikimasa Ishikawa, Akihiko Uchiyama, Shyuyo Umeda, Ryuji Nakano, Akiko Sagara, Toshinaga Nabae, Takakazu Sasaguri, Masahiko Kawamoto, Soichiro Murakami
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 48:977-983
Autor:
Ichiro Takaki, Ken-ichi Aoki, Norikuni Komine, Atsuko Iwasa, Ryuji Nakano, Gakusen Nishihara, Tomochika Nakamata
Publikováno v:
Journal of UOEH. 33:139-146
A 66 year old woman with end-stage renal disease and liver cirrhosis due to chronic hepatitis C virus infection was introduced to hemodialysis therapy in 2003. In 2007, hepatocellular carcinoma was identified and the patient underwent radio frequency